Myriad Genetics Inc (NASDAQ:MYGN)
| 26.58 Delayed Data As of Jan 21 |  -0.19 / -0.71%Today’s Change | 23.55 Today|||52-Week Range 36.95 | -3.70% Year-to-Date |
Latest MYGN News | Press Releases
No recent news for Myriad Genetics Inc.
Today’s Trading
| Previous close | 26.77 |
| Today’s open | 26.90 |
| Day’s range | 26.50 - 27.43 |
| Volume | 32,728 |
| Average volume (3 months) | 507,265 |
| Market cap | $2.2B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -4,389.30% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -24.97% |
| P/E ratio | NM |
| Price/Sales | 1.32 |
| Price/Book | 2.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CDNACareDx Inc | -0.93 | -2.45% |
| ---- | ||
| VCYTVeracyte Inc | -0.66 | -2.39% |
| LNTHLantheus Holdings In... | -0.59 | -2.28% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | March 2, 2022 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $638.6M |
| Annual profit (last year) | -$199.5M |
| Net profit margin | -31.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
